Tissue engineering therapy for atrophic maxilla using minimally manipulated CD90 and CD105 bone marrow stem cells: a case report

Vista sencilla de ítem
dc.contributor.authorValdivia, E.es_ES
dc.contributor.authorMendoza-Azpur, G.es_ES
dc.contributor.authorPando, J.es_ES
dc.contributor.authorCornejo, H.es_ES
dc.contributor.authorCarrasco, A.es_ES
dc.contributor.authorNevins, M.es_ES
dc.contributor.authorKim, D.es_ES
dc.date.accessioned6/22/2022 13:33
dc.date.accessioned2022-09-30T16:49:30Z
dc.date.available6/22/2022 13:33
dc.date.available2022-09-30T16:49:30Z
dc.date.issued2017
dc.description.abstractBone deficiencies in the jaws of edentulous patients limit the possibility of successful placement and osseointegration of endosseous implants. Bone resorption is defined as a vertical and horizontal loss of quality and quantity in the residual bone ridges; lack of bone structure requires bone grafting procedures to enable implant placement and to improve the function, predictability, and longevity of implants. The objective of this case study was to demonstrate the feasibility of a novel cell therapy treatment for localized jaw bone defects with tissue repair cells composed of a mixture of bone marrow-derived cells, including CD90+ mesenchymal stem cells and CD105+ monocytes/macrophages, and xenograft blocks, in what would be a safe and efficacious approach to the regeneration of localized craniofacial bone defects. The use of stem cells represents an alternative that could offer improved results, better quality histologically, and greater quantity in millimeters of tissue in bone regeneration. © 2017 by Quintessence Publishing Co Inc.es_ES
dc.formatapplication/pdfes_ES
dc.identifier.doi10.11607/prd.3119es_ES
dc.identifier.urihttps://doi.org/10.11607/prd.3119
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/28402346/es_PE
dc.identifier.urihttps://cris.cientifica.edu.pe/es/publications/tissue-engineering-therapy-for-atrophic-maxilla-using-minimally-m/fingerprints/?sortBy=alphabeticallyes_PE
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=85018634535&partnerID=8YFLogxKes_PE
dc.identifier.urihttps://eurekamag.com/research/060/405/060405795.phpes_PE
dc.identifier.urihttps://link.springer.com/chapter/10.1007/978-1-4939-1529-3_14es_PE
dc.language.isoenges_ES
dc.publisherQuintessence Publishing Co. Inc.es_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/es_ES
dc.sourceInternational Journal of Periodontics and Restorative Dentistryes_ES
dc.subjectMedicinees_ES
dc.subject.ocdehttp://purl.org/pe-repo/ocde/ford#3.00.00es_ES
dc.titleTissue engineering therapy for atrophic maxilla using minimally manipulated CD90 and CD105 bone marrow stem cells: a case reportes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersiones_ES
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
277. Tissue engineering therapy for atrophic maxilla using minimally manipulated CD90 and CD105 bone marrow stem cells A case report.PDF
Tamaño:
392.75 KB
Formato:
Adobe Portable Document Format
Descargar
Colecciones
Artículo